Get started
Author

Po Inglis

EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
2013 · Bryan W. Day, Brett W. Stringer, et al. · Cancer Cell · 221
PDF
Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research
2013 · Bryan Day, Brett Stringer, et al. · Cancers · 66
PDF
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1
2011 · Bryan W. Day, Brett W. Stringer, et al. · Neuro-Oncology · 38
Adult Wilms' Tumour: Case Report and Review of Literature
2016 · Sunny Modi, Kor Woi Tiang, et al. · Journal of Kidney Cancer and VHL · 31
PDF
Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma
2020 · Hui Gan, Lawrence Cher, et al. · Journal of Nuclear Medicine · 5
Atim-23. Preliminary Findings of a Phase I Safety and Bioimaging Trial of Kb004 (ifabotuzumab) in Patients With Glioblastoma
2019 · Hui Gan, Lawrence Cher, et al. · Neuro-Oncology · 5
Abstract CT063: Preliminary findings of a Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma
2019 · Hui Gan, Lawrence Cher, et al. · Cancer Research · 5
Abstract CT101: Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
2021 · Hui K. Gan, Lawrence Cher, et al. · Cancer Research
Abstract CT063: Preliminary findings of a Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma
2019 · Hui Gan, Lawrence Cher, et al. · Clinical Trials
Implementation of precision oncology in breast cancer care in Qld (Q-IMPROvE).
2019 · Amy E. McCart Reed, Peter T. Simpson, et al.
Abstract 1197: EphA3 kinase ablation induces glioblastoma differentiation and prevents tumor progression
2011 · Bryan W. Day, Michael J. Ting, et al. · Cancer Research
Works count: 11
Citation count: 371
H-index: 5
I10-index: 4
Year
Topic
Type